In a TMA analysis of PDA patients (Fig. 5a), patients were grouped into low or high expression groups based on median of PAK1 or PAK4 intensity as well as median percentage of CD4 + or CD8 + positive cells (Figs. 5b and 6a). This evidence concerns the gene CD8A and Patent ductus arteriosus.